PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2010
CASE
AUTH/2361/10/10 Cephalon ⭐ Case of the Week

Cephalon: Lisbon congress hospitality and an internal β€œfeedback” note that normalised excessive entertainment (AUTH/2361/10/10)

Cephalon’s internal congress feedback note described β€œclubbing” and late-night bars with HCPs and urged β€œlets make sure they start Rxing now!”. PMCPA…

2011
CASE
AUTH/2386/2/11 Bayer

AUTH/2386/2/11: Anonymous v Bayer β€” meeting sponsorship and alleged aggressive representative conduct (No breach)

Anonymous GP alleged a sponsored contraception update was disguised promotion and that a Bayer representative bullied delegates. Panel found sponsorship was clear…

2011
CASE
AUTH/2402/4/11 Bayer

Bayer: Product launch tweets for Levitra and Sativex accessible to the public (AUTH/2402/4/11)

Bayer posted two product-specific tweets about Levitra and Sativex from press release headlines. The tweets were not certified and were accessible to…

2008
CASE
Novo Nordisk

Baxter Healthcare v Novo Nordisk: NovoSeven leavepiece cost-effectiveness claim found misleading (Clause 7.3)

Novo Nordisk’s NovoSeven leavepiece claimed cost-effectiveness vs FEIBA using older efficacy inputs. PMCPA ruled the claim didn’t reflect the totality of evidence…

2018
CASE
AUTH/3096/9/18 Shire

AUTH/3096/9/18 Director v Shire: EU Clinical Trials Register disclosure (No breach)

BMJ analysis suggested Shire had unreported EUCTR trial results. PMCPA found the trials were out of UK Code scope or results were…

2011
CASE
AUTH/2409/6/11 Cephalon ⭐ Case of the Week

Anonymous v Cephalon (AUTH/2409/6/11): Promotional material certified by non‑GMC registered β€œmedical” signatory

Cephalon discovered an interim medical adviser who certified ~45 promotional items was not GMC registered. PMCPA found a breach of Clause 14.1…

2011
CASE
AUTH/2440/10/11 Boehringer Ingelheim

AUTH/2440/10/11 & AUTH/2441/10/11: GP complaint over Trajenta press release β€˜class-comparable efficacy’ claim (Boehringer Ingelheim & Lilly)

A GP challenged a Trajenta launch press release claiming β€œclass-comparable efficacy”. PMCPA ruled the indirect SPC-based comparison was misleading, unsubstantiated and exaggerated.…

2018
CASE
AUTH/3120/11/18 Shire

AUTH/3120/11/18: Director v Shire β€” Clinical trial disclosure (outwith scope; no breach)

PMCPA case AUTH/3120/11/18 (Director v Shire) about clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…

2018
CASE
AUTH/3077/9/18 Otsuka

AUTH/3077/9/18: Director v Otsuka UK β€” Clinical trial disclosure (outwith scope; no breach)

PMCPA case AUTH/3077/9/18 (Otsuka UK) concerned clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016). No…

2012
CASE
Merck Serono

Merck Serono: patient support website emails used for market research survey invitation (no breach)

A patient received a survey invite from a market research agency after registering on a Rebif support site. She alleged improper sharing…

2012
CASE
AUTH/2500/4/12 Eisai ⭐ Case of the Week

Eisai breached ABPI Code over Zonegran detail aid implying weight-loss benefit (AUTH/2500/4/12)

Anonymous neurologist alleged Zonegran promotion implied use in overweight epileptics. PMCPA found the detail aid misleading on weight effects, exaggerating properties and…

2011
CASE
AUTH/2478/2/11 GlaxoSmithKline

GSK Seretide pricing and NHS β€œvalue” email: complaint not upheld (AUTH/2478/2/11)

A pharmacist challenged GSK claims that Seretide was β€œpriced competitively” and could help NHS QIPP targets. The PMCPA Panel found both claims…

2011
CASE
AUTH/2442/10/11 Vifor Pharma

AUTH/2442/10/11: Pharmacosmos v Vifor β€” breach of undertaking over Ferinject hypersensitivity claim in website press releases

Vifor left two website press releases live containing a Ferinject claim previously ruled misleading about hypersensitivity. PMCPA found a breach of undertaking…

2011
CASE
AUTH/2435/8/11 Chiesi

AUTH/2435/8/11: Chiesi ruled in breach for promoting Fostair in COPD at an international symposium and for breaching an undertaking

GSK alleged Chiesi promoted Fostair for COPD before UK authorisation via an ATS symposium and a sponsored journal. PMCPA found off-label promotion,…

2012
CASE
Recordati

Recordati: ISU Belfast urology meeting sponsorship criticised due to overall impression of luxury venue and social programme (Clause 9.1 breach)

Anonymous NHS HCPs complained about excessive hospitality at an ISU meeting in Belfast (5-star venue, golf, gala dinner). For Recordati, PMCPA found…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training